Last reviewed: June 22, 2026

Last updated: June 22, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, the active ingredient in Wegovy, has shown a 15% average body weight reduction in clinical trials. Yet brand-name Wegovy remains expensive and often unavailable due to supply constraints. PlexusDx provides access to compounded semaglutide and other GLP-1 medications through licensed 503A pharmacies, eliminating insurance barriers and offering transparent pricing.

Why Wegovy Costs So Much

Wegovy's manufacturer charges between $900 and $1,500 per month depending on dose level and insurance status. Even with commercial insurance, patients often face high deductibles and prior authorization delays that can take weeks. The brand-name premium reflects research and development costs, regulatory exclusivity, and limited manufacturing capacity that has created persistent shortages.

Insurance coverage for Wegovy varies widely. Many plans require proof of a BMI over 27 with at least one weight-related comorbidity, or a BMI exceeding 30. Some insurers deny coverage altogether, forcing patients to pay cash at full retail price. This gatekeeping creates a two-tier system where only insured individuals in specific income brackets can afford treatment.

How PlexusDx Compounded GLP-1 Pricing Works

PlexusDx compounded semaglutide injection begins at $149 per month and remains flat across all dose levels. Your dose may need to go up. Your price won't. This transparent model eliminates the surprise costs and escalating fees tied to dose adjustments that occur with brand-name medications. Patients across all 50 states access the same pricing structure regardless of insurance status.

The Microdose GLP-1 Protocol starts at just $129 per month, designed for patients starting GLP-1 therapy or preferring lower initial doses. Compounded tirzepatide injection, a dual-action GLP-1/GIP receptor agonist, begins at $249 per month. Oral formulations are also available. PlexusDx medications come from licensed 503A compounding pharmacies that meet strict quality and sterility standards.

Cost Comparison: Brand vs. Compounded GLP-1

A patient paying out-of-pocket for 12 months of Wegovy at $1,200 per month spends $14,400 annually. The same patient on PlexusDx compounded semaglutide at $149 per month pays $1,788 per year—a reduction of over 87%. Even accounting for individual dose adjustments, compounded GLP-1 remains significantly more affordable than brand-name alternatives.

Insurance does not always lower true costs. Patients with high-deductible plans may pay $500 or more monthly out-of-pocket before coverage begins. PlexusDx eliminates this uncertainty. HSA and FSA accounts cover PlexusDx medications, allowing pre-tax savings that further reduce effective cost. No membership fees, no insurance prerequisite, and no authorization delays speed access to treatment.

Personalized Dosing Without Higher Prices

Weight loss with GLP-1 agonists requires dose escalation over 12–16 weeks as the body adapts to the medication. Brand-name pricing structures penalize dose increases with higher monthly bills. PlexusDx maintains a single monthly price regardless of whether a patient is on 0.25 mg or 2.4 mg of compounded semaglutide. This design prioritizes clinical outcomes over financial barriers.

The Precision Peptide Genetic Test, available as a $99 add-on after the first month of treatment, maps 14 peptide pathways and identifies 150+ genetic insights. Key variants like GIPR rs1800437 and GLP1R rs6923761 help PlexusDx providers predict individual semaglutide or tirzepatide responsiveness. Personalized selection based on your genetics improves outcomes while keeping costs predictable.

What's Included in PlexusDx Monthly Fees

PlexusDx pricing includes the medication itself, pharmacy compounding and quality assurance, and telehealth provider oversight. Patients receive ongoing support for dose management, side-effect navigation, and dietary counseling at no additional charge. Blood work and genetic testing are optional add-ons that enhance personalization without mandatory fees.

Unlike subscription boxes or membership-based telehealth platforms, PlexusDx charges only for medications you actually use. Cancel anytime without penalty. Three commitment tiers offer modest discounts for annual and quarterly prepayment, but monthly flexibility remains available. This transparency and choice distinguish PlexusDx from competitors offering bundled packages that hide true medication costs.

Access and Eligibility Across All 50 States

PlexusDx serves residents of all 50 states without insurance requirements or geographic restrictions. A licensed provider evaluates medical history and current medications during a brief telehealth consultation. Medications ship directly from licensed 503A compounding pharmacies to your home within 3–5 business days. No pharmacy network limitations apply.

Patients with chronic kidney disease, heart failure, or a history of medullary thyroid cancer require additional screening before GLP-1 therapy. PlexusDx providers conduct thorough intake to identify contraindications and ensure safe treatment. Pregnancy and breastfeeding also warrant caution and provider discussion. This clinical oversight maintains safety while maximizing access for eligible candidates.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Microdose Glp1 Protocol starts at $129/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How much does PlexusDx compounded semaglutide cost compared to Wegovy?

PlexusDx compounded semaglutide injection starts at $149 per month, while brand-name Wegovy costs $900–$1,500 monthly. Your dose may need to go up. Your price won't. This flat pricing applies across all dose levels, saving most patients over $10,000 annually versus out-of-pocket Wegovy costs.

Is the Microdose GLP-1 Protocol right for me if I'm new to weight loss medication?

Yes, the Microdose GLP-1 Protocol at $129 per month is designed for first-time users or those preferring conservative initial dosing. It allows your body to adapt gradually while minimizing nausea and gastrointestinal side effects. A PlexusDx provider will assess whether microdosing or standard escalation suits your health history.

Do HSA or FSA accounts cover PlexusDx medications?

Yes, all PlexusDx compounded GLP-1 medications and the Precision Peptide Genetic Test are HSA and FSA eligible. This allows you to pay with pre-tax dollars, further reducing your effective out-of-pocket cost. Check with your account administrator for any plan-specific restrictions.

Are compounded medications from PlexusDx as safe as brand-name Wegovy?

PlexusDx compounded medications come from licensed 503A compounding pharmacies that meet rigorous FDA oversight and sterility standards. The active ingredients are identical to brand medications; compounding allows flexible dosing and lower cost. Potential side effects—nausea, constipation, pancreatitis risk—are the same across compounded and brand formulations and require provider monitoring.

How does the Precision Peptide Genetic Test help me choose between semaglutide and tirzepatide?

The Precision Peptide Genetic Test identifies variants in key receptors like GLP1R and GIPR that influence how your body responds to GLP-1 and GIP agonists. PlexusDx providers use these 150+ genetic insights to predict whether semaglutide or tirzepatide is likely to produce superior weight loss for your unique biology, improving treatment success.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves